These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 18190604

  • 1. New immunological serum markers in bacteraemia: anti-inflammatory soluble CD163, but not proinflammatory high mobility group-box 1 protein, is related to prognosis.
    Gaïni S, Pedersen SS, Koldkaer OG, Pedersen C, Moestrup SK, Møller HJ.
    Clin Exp Immunol; 2008 Mar; 151(3):423-31. PubMed ID: 18190604
    [Abstract] [Full Text] [Related]

  • 2. Macrophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163.
    Møller HJ, Moestrup SK, Weis N, Wejse C, Nielsen H, Pedersen SS, Attermann J, Nexø E, Kronborg G.
    Crit Care Med; 2006 Oct; 34(10):2561-6. PubMed ID: 16915112
    [Abstract] [Full Text] [Related]

  • 3. High mobility group box-1 protein in patients with suspected community-acquired infections and sepsis: a prospective study.
    Gaïni S, Pedersen SS, Koldkjaer OG, Pedersen C, Møller HJ.
    Crit Care; 2007 Oct; 11(2):R32. PubMed ID: 17346334
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Soluble haemoglobin scavenger receptor (sCD163) in patients with suspected community-acquired infections.
    Gaïni S, Koldkjaer OG, Pedersen SS, Pedersen C, Moestrup SK, Møller HJ.
    APMIS; 2006 Feb; 114(2):103-11. PubMed ID: 16519746
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD.
    Axelsson J, Møller HJ, Witasp A, Qureshi AR, Carrero JJ, Heimbürger O, Bárány P, Alvestrand A, Lindholm B, Moestrup SK, Stenvinkel P.
    Am J Kidney Dis; 2006 Dec; 48(6):916-25. PubMed ID: 17162146
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of soluble CD163 as a marker of inflammation in psoriasis.
    Feighery C, Dunne J, Bingham EA, Feighery CF.
    Clin Exp Dermatol; 2011 Mar; 36(2):201-3. PubMed ID: 21323937
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Soluble CD163 and interleukin-6 are increased in aqueous humour from patients with endothelial rejection of corneal grafts.
    Funding M, Vorum H, Nexø E, Moestrup SK, Ehlers N, Møller HJ.
    Acta Ophthalmol Scand; 2005 Apr; 83(2):234-9. PubMed ID: 15799739
    [Abstract] [Full Text] [Related]

  • 12. Peripheral artery disease is associated with a high CD163/TWEAK plasma ratio.
    Moreno JA, Dejouvencel T, Labreuche J, Smadja DM, Dussiot M, Martin-Ventura JL, Egido J, Gaussem P, Emmerich J, Michel JB, Blanco-Colio LM, Meilhac O.
    Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1253-62. PubMed ID: 20299688
    [Abstract] [Full Text] [Related]

  • 13. Predictive value of soluble haemoglobin scavenger receptor CD163 serum levels for survival in verified tuberculosis patients.
    Knudsen TB, Gustafson P, Kronborg G, Kristiansen TB, Moestrup SK, Nielsen JO, Gomes V, Aaby P, Lisse I, Møller HJ, Eugen-Olsen J.
    Clin Microbiol Infect; 2005 Sep; 11(9):730-5. PubMed ID: 16104988
    [Abstract] [Full Text] [Related]

  • 14. Serum markers of macrophage activation in pre-eclampsia: no predictive value of soluble CD163 and neopterin.
    Kronborg CS, Knudsen UB, Moestrup SK, Allen J, Vittinghus E, Møller HJ.
    Acta Obstet Gynecol Scand; 2007 Sep; 86(9):1041-6. PubMed ID: 17712642
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Significant increase of serum high-mobility group box chromosomal protein 1 levels in patients with severe acute pancreatitis.
    Yasuda T, Ueda T, Takeyama Y, Shinzeki M, Sawa H, Nakajima T, Ajiki T, Fujino Y, Suzuki Y, Kuroda Y.
    Pancreas; 2006 Nov; 33(4):359-63. PubMed ID: 17079940
    [Abstract] [Full Text] [Related]

  • 18. Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure.
    Hiraoka A, Horiike N, Akbar SM, Michitaka K, Matsuyama T, Onji M.
    J Gastroenterol; 2005 Jan; 40(1):52-6. PubMed ID: 15692789
    [Abstract] [Full Text] [Related]

  • 19. Soluble CD163: An age-dependent, anti-inflammatory biomarker predicting outcome in sepsis.
    Weiss M, Schneider EM.
    Crit Care Med; 2006 Oct; 34(10):2682-3. PubMed ID: 16983269
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.